LIF mediates proinvasive activation of stromal fibroblasts in cancer

Cell Reports

Volumn 7, Issue 5, 2014, Pages 1664-1678

  Albrengues, Jean ^a   Bourget, Isabelle ^a   Pons, Catherine ^a   Butet, Vincent ^b   Hofman, Paul ^c   Tartare Deckert, Sophie ^a   Feral, ChloeC ^a   Meneguzzi, Guerrino ^a   Gaggioli, Cedric ^a  

^a INSERM   (France)

^b Pathological Anatomy and Cytology Laboratory   (France)

^c PASTEUR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN FIBER; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; MYOSIN ADENOSINE TRIPHOSPHATASE; RUXOLITINIB; TRANSFORMING GROWTH FACTOR BETA; JANUS KINASE 1; JANUS KINASE 2; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOMA CELL; CELL ACTIVATION; CELL INVASION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENSE BODY; DRUG MECHANISM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; TUMOR CELL; UPREGULATION; BREAST CARCINOMA; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR MICROENVIRONMENT;

EID: 84902328340     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.04.036     Document Type: Article

References (57)

1. Achyut B.R., Bader D.A., Robles A.I., Wangsa D., Harris C.C., Ried T., Yang L. Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling. PLoS Genet. 2013, 9:e1003251.
2. Aslakson C.J., Miller F.R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992, 52:1399-1405.
3. Beacham D.A., Cukierman E. Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin. Cancer Biol. 2005, 15:329-341.
4. Berishaj M., Gao S.P., Ahmed S., Leslie K., Al-Ahmadie H., Gerald W.L., Bornmann W., Bromberg J.F. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast Cancer Res. 2007, 9:R32.
5. Bhowmick N.A., Chytil A., Plieth D., Gorska A.E., Dumont N., Shappell S., Washington M.K., Neilson E.G., Moses H.L. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004, 303:848-851.
6. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
7. Boyd N.F., Guo H., Martin L.J., Sun L., Stone J., Fishell E., Jong R.A., Hislop G., Chiarelli A., Minkin S., Yaffe M.J. Mammographic density and the risk and detection of breast cancer. N.Engl. J. Med. 2007, 356:227-236.
8. Calvo F., Sahai E. Cell communication networks in cancer invasion. Curr. Opin. Cell Biol. 2011, 23:621-629.
9. Calon A., Espinet E., Palomo-Ponce S., Tauriello D.V., Iglesias M., Céspedes M.V., Sevillano M., Nadal C., Jung P., Zhang X.H., et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell 2012, 22:571-584.
10. Calvo F., Ege N., Grande-Garcia A., Hooper S., Jenkins R.P., Chaudhry S.I., Harrington K., Williamson P., Moeendarbary E., Charras G., Sahai E. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat. Cell Biol. 2013, 15:637-646.
11. Canady J., Arndt S., Karrer S., Bosserhoff A.K. Increased KGF Expression Promotes Fibroblast Activation in a Double Paracrine Manner Resulting in Cutaneous Fibrosis. J.Invest. Dermatol. 2013, 133:647-657.
12. Chen D., Sun Y., Wei Y., Zhang P., Rezaeian A.H., Teruya-Feldstein J., Gupta S., Liang H., Lin H.K., Hung M.C., Ma L. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat. Med. 2012, 18:1511-1517.
13. Clark E.A., Golub T.R., Lander E.S., Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000, 406:532-535.
14. Connolly E.C., Freimuth J., Akhurst R.J. Complexities of TGF-β targeted cancer therapy. Int. J. Biol. Sci. 2012, 8:964-978.
15. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
16. Croft D.R., Olson M.F. Conditional regulation of a ROCK-estrogen receptor fusion protein. Methods Enzymol. 2006, 406:541-553.
17. De Wever O., Demetter P., Mareel M., Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer 2008, 123:2229-2238.
18. Dees C., Tomcik M., Palumbo-Zerr K., Distler A., Beyer C., Lang V., Horn A., Zerr P., Zwerina J., Gelse K., et al. JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis. Arthritis Rheum. 2012, 64:3006-3015.
19. Desmoulière A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J.Cell Biol. 1993, 122:103-111.
20. Erez N., Truitt M., Olson P., Arron S.T., Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010, 17:135-147.
21. Franco O.E., Jiang M., Strand D.W., Peacock J., Fernandez S., Jackson R.S., Revelo M.P., Bhowmick N.A., Hayward S.W. Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Res. 2011, 71:1272-1281.
22. Gaggioli C., Hooper S., Hidalgo-Carcedo C., Grosse R., Marshall J.F., Harrington K., Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 2007, 9:1392-1400.
23. García-Tuñón I., Ricote M., Ruiz A., Fraile B., Paniagua R., Royuela M. OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative). Cancer Invest. 2008, 26:222-229.
24. Goetz J.G., Minguet S., Navarro-Lérida I., Lazcano J.J., Samaniego R., Calvo E., Tello M., Osteso-Ibáñez T., Pellinen T., Echarri A., et al. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 2011, 146:148-163.
25. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
26. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell 2001, 12:2730-2741.
27. Hooper S., Gaggioli C., Sahai E. A chemical biology screen reveals a role for Rab21-mediated control of actomyosin contractility in fibroblast-driven cancer invasion. Br. J. Cancer 2010, 102:392-402.
28. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
29. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
30. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995, 86:1243-1254.
31. Lederle W., Depner S., Schnur S., Obermueller E., Catone N., Just A., Fusenig N.E., Mueller M.M. IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines. Int. J. Cancer 2011, 128:2803-2814.
32. Levental K.R., Yu H., Kass L., Lakins J.N., Egeblad M., Erler J.T., Fong S.F., Csiszar K., Giaccia A., Weninger W., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906.
33. Lin X.D., Chen S.Q., Qi Y.L., Zhu J.W., Tang Y., Lin J.Y. Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma. J.Surg. Oncol. 2012, 106:94-100.
34. Mascarenhas J., Hoffman R. Ruxolitinib: the first FDA approved therapy for the treatment of myelofibrosis. Clin. Cancer Res. 2012, 18:3008-3014.
35. Mordasky Markell L., Pérez-Lorenzo R., Masiuk K.E., Kennett M.J., Glick A.B. Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression. Carcinogenesis 2010, 31:2127-2135.
36. Navab R., Strumpf D., Bandarchi B., Zhu C.Q., Pintilie M., Ramnarine V.R., Ibrahimov E., Radulovich N., Leung L., Barczyk M., et al. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc. Natl. Acad. Sci. USA 2011, 108:7160-7165.
37. O'Donoghue R.J., Knight D.A., Richards C.D., Prêle C.M., Lau H.L., Jarnicki A.G., Jones J., Bozinovski S., Vlahos R., Thiem S., et al. Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol Med 2012, 4:939-951.
38. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999, 59:5002-5011.
39. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., Weinberg R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
40. Pardanani A., Lasho T., Smith G., Burns C.J., Fantino E., Tefferi A. CYT387, a selective JAK1/JAK2 inhibitor: invitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients. Leukemia 2009, 23:1441-1445.
41. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., Reinhart-King C.A., Margulies S.S., Dembo M., Boettiger D., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254.
42. Peñuelas S., Anido J., Prieto-Sánchez R.M., Folch G., Barba I., Cuartas I., García-Dorado D., Poca M.A., Sahuquillo J., Baselga J., Seoane J. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 2009, 15:315-327.
43. Phan S.H. Biology of fibroblasts and myofibroblasts. Proc. Am. Thorac. Soc. 2008, 5:334-337.
44. Provenzano P.P., Inman D.R., Eliceiri K.W., Knittel J.G., Yan L., Rueden C.T., White J.G., Keely P.J. Collagen density promotes mammary tumor initiation and progression. BMC Med. 2008, 6:11.
45. Samuel M.S., Lopez J.I., McGhee E.J., Croft D.R., Strachan D., Timpson P., Munro J., Schröder E., Zhou J., Brunton V.G., et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell 2011, 19:776-791.
46. Sanz-Moreno V., Gaggioli C., Yeo M., Albrengues J., Wallberg F., Viros A., Hooper S., Mitter R., Féral C.C., Cook M., et al. ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell 2011, 20:229-245.
47. Scholz A., Heinze S., Detjen K.M., Peters M., Welzel M., Hauff P., Schirner M., Wiedenmann B., Rosewicz S. Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology 2003, 125:891-905.
48. Shi M., Yu D.H., Chen Y., Zhao C.Y., Zhang J., Liu Q.H., Ni C.R., Zhu M.H. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. World J. Gastroenterol. 2012, 18:840-846.
49. Sriuranpong V., Park J.I., Amornphimoltham P., Patel V., Nelkin B.D., Gutkind J.S. Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res. 2003, 63:2948-2956.
50. Sugimoto H., Mundel T.M., Kieran M.W., Kalluri R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol. Ther. 2006, 5:1640-1646.
51. Szepietowski J.C., Reich A., McKenzie R.C. The multifunctional role of leukaemia inhibitory factor in cutaneous biology. Acta Dermatovenerol. Alp. Panonica Adriat. 2004, 13:125-129.
52. Takahashi Y., Ishii G., Taira T., Fujii S., Yanagi S., Hishida T., Yoshida J., Nishimura M., Nomori H., Nagai K., Ochiai A. Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients. J.Thorac. Oncol. 2011, 6:1460-1467.
53. Trimboli A.J., Cantemir-Stone C.Z., Li F., Wallace J.A., Merchant A., Creasap N., Thompson J.C., Caserta E., Wang H., Chong J.L., et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009, 461:1084-1091.
54. Wynn T.A., Ramalingam T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 2012, 18:1028-1040.
55. Wysoczynski M., Miekus K., Jankowski K., Wanzeck J., Bertolone S., Janowska-Wieczorek A., Ratajczak J., Ratajczak M.Z. Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. Cancer Res. 2007, 67:2131-2140.
56. Yamashita M., Ogawa T., Zhang X., Hanamura N., Kashikura Y., Takamura M., Yoneda M., Shiraishi T. Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome. Breast Cancer 2012, 19:170-176.
57. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.